NYSE:STE - アナリストの将来予測と過去の財務データ ( )USD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
3/31/2027	6,156	891	1,276	1,656	5
3/31/2026	5,835	758	1,101	1,353	8
3/31/2025	5,529	658	797	1,115	9
3/31/2024	5,139	551	613	973	N/A
12/31/2023	5,407	567	594	934	N/A
9/30/2023	5,228	550	535	849	N/A
6/30/2023	5,086	119	494	806	N/A
3/31/2023	4,536	557	395	757	N/A
12/31/2022	4,784	-28	349	713	N/A
9/30/2022	4,777	-8	399	752	N/A
6/30/2022	4,773	377	472	819	N/A
3/31/2022	4,223	285	397	685	N/A
12/31/2021	4,248	279	412	701	N/A
9/30/2021	3,848	250	400	662	N/A
6/30/2021	3,407	286	424	653	N/A
3/31/2021	3,108	397	450	690	N/A
12/31/2020	3,057	433	476	701	N/A
9/30/2020	3,022	424	400	627	N/A
6/30/2020	3,003	413	384	615	N/A
3/31/2020	3,031	408	376	591	N/A
12/31/2019	2,976	393	340	570	N/A
9/30/2019	2,898	336	347	573	N/A
6/30/2019	2,840	319	336	548	N/A
3/31/2019	2,782	304	350	540	N/A
12/31/2018	2,730	269	325	490	N/A
9/30/2018	2,696	316	314	467	N/A
6/30/2018	2,651	303	321	478	N/A
3/31/2018	2,620	291	292	458	N/A
12/31/2017	2,585	243	N/A	463	N/A
9/30/2017	2,570	144	N/A	453	N/A
6/30/2017	2,582	120	N/A	424	N/A
3/31/2017	2,613	110	N/A	424	N/A
12/31/2016	2,616	142	N/A	439	N/A
9/30/2016	2,588	167	N/A	364	N/A
6/30/2016	2,431	135	N/A	294	N/A
3/31/2016	2,233	111	N/A	255	N/A
12/31/2015	2,042	94	N/A	185	N/A
9/30/2015	1,897	113	N/A	221	N/A
6/30/2015	1,870	135	N/A	241	N/A
3/31/2015	1,842	135	N/A	246	N/A
12/31/2014	1,807	133	N/A	233	N/A
9/30/2014	1,739	123	N/A	234	N/A
6/30/2014	1,660	122	N/A	223	N/A
3/31/2014	1,615	129	N/A	210	N/A
12/31/2013	1,585	132	N/A	189	N/A
9/30/2013	1,560	152	N/A	196	N/A
6/30/2013	1,533	162	N/A	199	N/A

アナリストによる今後の成長予測

収入対貯蓄率: STEの予測収益成長率 (年間12.2% ) は貯蓄率 ( 2.4% ) を上回っています。

収益対市場: STEの収益 ( 12.2% ) US市場 ( 14.8% ) よりも低い成長が予測されています。

高成長収益: STEの収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: STEの収益 ( 6.1% ) US市場 ( 8.7% ) よりも低い成長が予測されています。

高い収益成長: STEの収益 ( 6.1% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: STEの自己資本利益率は、3年後には低くなると予測されています ( 11.9 %)。

STERIS 将来の成長

Future 基準チェック /16

主要情報

今後の成長に関する最新情報

STERIS plc Provides Earnings Guidance for the Fiscal Year 2025

STERIS plc Revises Financial Guidance for the Fiscal Year 2024

STERIS plc Confirms Earnings Guidance for the Fiscal Year 2024

STERIS plc Confirms Earnings Guidance for the Fiscal Year 2024

STERIS plc Provides Revenue Guidance for the Fiscal Year 2024

STERIS plc Updates Financial Guidance for the Fiscal Year Ending March 31, 2023

Recent updates

STERIS plc, Annual General Meeting, Aug 01, 2024

Is STERIS (NYSE:STE) Using Too Much Debt?

Senior VP & President of Healthcare notifies of intention to sell stock

Upcoming dividend of US$0.52 per share

Insufficient new directors

Independent Director notifies of intention to sell stock

STERIS plc Provides Earnings Guidance for the Fiscal Year 2025

Full year 2024 earnings: EPS misses analyst expectations

Third quarter dividend of US$0.52 announced

STERIS plc Announces Quarterly Interim Dividend, Payable on June 26, 2024

STERIS plc to Report Q4, 2024 Results on May 08, 2024

Steris: Moving On, Losing Its Teeth

STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 31% Above Its Share Price

STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet

Steris: Strong Healthcare Products Growth Coupled With Weak AST Business

STERIS plc's (NYSE:STE) Business Is Trailing The Industry But Its Shares Aren't

Upcoming dividend of US$0.52 per share at 0.9% yield

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

STERIS plc Revises Financial Guidance for the Fiscal Year 2024

Second quarter dividend of US$0.52 announced

STERIS plc Announces Quarterly Interim Dividend, Payable on March 22, 2024

Now 21% undervalued

STERIS plc to Report Q3, 2024 Results on Feb 07, 2024

Now 20% undervalued

An Intrinsic Calculation For STERIS plc (NYSE:STE) Suggests It's 23% Undervalued

Should You Investigate STERIS plc (NYSE:STE) At US$203?

Upcoming dividend of US$0.52 per share at 1.0% yield

STERIS plc Confirms Earnings Guidance for the Fiscal Year 2024

STERIS plc Confirms Earnings Guidance for the Fiscal Year 2024

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Steris: Comprehensive Sterilization Portfolios Tailored To Procedure Volumes

We Think STERIS (NYSE:STE) Can Stay On Top Of Its Debt

STERIS plc Announces Quarterly Interim Dividend, Payable on December 21, 2023

STERIS plc to Report Q2, 2024 Results on Nov 07, 2023

Are STERIS plc (NYSE:STE) Investors Paying Above The Intrinsic Value?

Steris: Remains On Track For Strong Fiscal '24, Added Upsides From Operating Leverage

Upcoming dividend of US$0.52 per share at 0.9% yield

When Should You Buy STERIS plc (NYSE:STE)?

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

STERIS plc Appoints Dr. Esther Alegria to Serve on the Compliance and Technology Committee and the Nominating and Governance Committee of the Board

STERIS plc to Report Q1, 2024 Results on Aug 01, 2023

Steris: Continuing To Grow The Product Lineup

STERIS plc, Annual General Meeting, Jul 27, 2023

Upcoming dividend of US$0.47 per share at 0.9% yield

Independent Director recently sold US$578k worth of stock

Independent Director exercised options and sold US$785k worth of stock

STERIS plc Provides Revenue Guidance for the Fiscal Year 2024

Full year 2023 earnings: EPS and revenues exceed analyst expectations

STERIS plc (NYSE:STE) announces an Equity Buyback for $500 million worth of its shares.

Insider recently sold US$219k worth of stock

Independent Director exercised options to buy US$863k worth of stock.

Upcoming dividend of US$0.47 per share at 0.9% yield

Third quarter 2023 earnings: Revenues miss analyst expectations

Steris falls 10% on Q3 revenue, profit miss, 2023 profit guidance lowered

STERIS plc Updates Financial Guidance for the Fiscal Year Ending March 31, 2023

STERIS plc Declares Quarterly Interim Dividend, Payable on March 23, 2023

Steris declares $0.47 dividend

These 4 Measures Indicate That STERIS (NYSE:STE) Is Using Debt Reasonably Well

STERIS plc to Report Q3, 2023 Results on Feb 08, 2023

Calculating The Intrinsic Value Of STERIS plc (NYSE:STE)

Insider recently sold US$308k worth of stock

Upcoming dividend of US$0.47 per share

STERIS plc Revises Earnings Guidance for the Fiscal Year 2023

Second quarter 2023 earnings: Revenues miss analyst expectations

STERIS plc Declares Interim Dividend, Payable on December 16, 2022

Steris declares $0.47 dividend

STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly

Price target decreased to US$230

STERIS plc to Report Q2, 2023 Results on Nov 09, 2022